Literature DB >> 11225474

[Lactobacillus paracasei endocarditis in an 18-yeard-old patient with trisomy 21, atrioventricular septal defect and Eisenmenger complex: therapeutic problems].

V Schmidt1, M Wolter, U Lenschow, W Kienast.   

Abstract

Endocarditis caused by lactobacilli is very rare and so far has been rarely published in adults with cardiac valve diseases especially after dental manipulations. Because of diagnostic and therapeutical problems we hereby report on one case of a female adolescent with Down's syndrome who did not undergo surgical correction of atrioventricular septal defect because of early development of Eisenmenger's syndrome. The onset was subacut and the diagnostic procedures were considerably delayed. Risk factors for the development of endocarditis in this case were preceding antibiotic treatments which increased the risk of selective growth of the causative germs as well as the tricuspidal valve incompetence with simultaneous pulmonary hypertension. The antimicrobial treatment was difficult due to resistance to antibiotic drugs generally applied in such cases and the restricted bacteriological diagnostic methods. Finally we had successfully administered chloramphenicol. The course was complicated by cerebral embolic events. FACIT: Lactobacillus species are facultative pathogenic which should be consideration in cases of subacute endocarditis in children and adolescents with ventricular septal defects and valve diseases. The determination of minimal bactericidal concentration of antibiotic agents and time-kill studies of combined antibiotics are recommended. For initial therapy we recommend high dose penicillin combined with an aminoglycoside. In cases of resistance chloramphenicol should be taken into account as second choice antibiotic drug. The duration of antibiotic therapy should at least over six weeks. In cases of risk systemic embolization is suspected therapy with low dose acetylsalicyclic acid or cardiosurgery should be assumed as therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11225474     DOI: 10.1055/s-2001-11272

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  3 in total

Review 1.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

2.  Prosthetic Aortic Valve Endocarditis in a Patient With Birt-Hogg-Dube Syndrome due to Lactobacillus paracasei.

Authors:  Mustafa Ajam; Omeralfaroug Adam; Ahmed Yeddi; Mowyad Kahlid; Mohamed Shokr; Luis Afonso
Journal:  Cardiol Res       Date:  2019-07-31

3.  Lactobacillus endocarditis: a case report in France and literature review.

Authors:  J Campagne; J F Guichard; M C Moulhade; H Kawski; F Maurier
Journal:  IDCases       Date:  2020-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.